1. Home
  2. ADAP

as 06-13-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Founded: 2008 Country:
United Kingdom
United Kingdom
Employees: N/A City: ABINGDON, OXFORDSHIRE
Market Cap: 268.3M IPO Year: 2015
Target Price: $4.29 AVG Volume (30 days): 1.5M
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.66 EPS Growth: N/A
52 Week Low/High: $0.42 - $2.05 Next Earning Date: 08-07-2024
Revenue: $18,358,000 Revenue Growth: -74.21%
Revenue Growth (this year): -6.68% Revenue Growth (next year): -31.64%

ADAP Daily Stock ML Predictions

Stock Insider Trading Activity of Adaptimmune Therapeutics plc (ADAP)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Rawcliffe Adrian ADAP Chief Executive Officer Jan 16 '24 Sell $0.79 9,304 $7,350.16 14,104 SEC Form 4
Rawcliffe Adrian ADAP Chief Executive Officer Jan 16 '24 Sell $0.67 30,080 $20,243.84 44,848 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 16 '24 Sell $0.79 4,681 $3,697.99 7,023 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 16 '24 Sell $0.67 5,309 $3,572.96 7,785 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 16 '24 Sell $0.67 12,805 $8,617.77 19,015 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 16 '24 Sell $0.79 4,681 $3,697.99 7,023 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 16 '24 Sell $0.67 5,309 $3,572.96 7,785 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 16 '24 Sell $0.67 13,599 $9,152.13 20,201 SEC Form 4
Norry Elliot ADAP Chief Medical Officer Jan 11 '24 Sell $0.85 7,799 $6,661.13 11,841 SEC Form 4
Norry Elliot ADAP Chief Medical Officer Jan 11 '24 Sell $0.84 4,009 $3,354.33 6,104 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 11 '24 Sell $0.84 4,009 $3,354.33 6,104 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 11 '24 Sell $0.85 5,220 $4,458.40 7,874 SEC Form 4
Rawcliffe Adrian ADAP Chief Executive Officer Jan 11 '24 Sell $0.84 11,945 $9,994.38 18,395 SEC Form 4
Rawcliffe Adrian ADAP Chief Executive Officer Jan 11 '24 Sell $0.85 17,257 $14,739.20 26,388 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 11 '24 Sell $0.84 4,009 $3,354.33 6,104 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 11 '24 Sell $0.85 5,220 $4,458.40 7,874 SEC Form 4

Share on Social Networks: